These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29641241)

  • 1. N-Acetyl Cysteine and Curcumin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
    Moore K
    J Child Adolesc Psychopharmacol; 2018 May; 28(4):293-294. PubMed ID: 29641241
    [No Abstract]   [Full Text] [Related]  

  • 2. Course of Neuropsychiatric Symptoms After Introduction and Removal of Nonsteroidal Anti-Inflammatory Drugs: A Pediatric Observational Study.
    Spartz EJ; Freeman GM; Brown K; Farhadian B; Thienemann M; Frankovich J
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):652-659. PubMed ID: 28696783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Survey of Pediatric Acute-Onset Neuropsychiatric Syndrome Characteristics and Course.
    Calaprice D; Tona J; Parker-Athill EC; Murphy TK
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):607-618. PubMed ID: 28140619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Double-Blind Randomized Placebo-Controlled Pilot Study of Azithromycin in Youth with Acute-Onset Obsessive-Compulsive Disorder.
    Murphy TK; Brennan EM; Johnco C; Parker-Athill EC; Miladinovic B; Storch EA; Lewin AB
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):640-651. PubMed ID: 28358599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.
    Percinel I; Yazici KU
    J Clin Psychopharmacol; 2014 Dec; 34(6):772-4. PubMed ID: 25203471
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral acetylcysteine for neuropsychiatric disorders.
    Racz R; Sweet BV; Sohoni P
    Am J Health Syst Pharm; 2015 Jun; 72(11):923-6, 928-9. PubMed ID: 25987686
    [No Abstract]   [Full Text] [Related]  

  • 7. N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder.
    Bhaskara S
    J Psychiatry Neurosci; 2019 May; 44(3):215-216. PubMed ID: 31038300
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
    J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
    Smith L; Tracy DK; Giaroli G
    J Clin Psychopharmacol; 2016 Feb; 36(1):57-62. PubMed ID: 26629962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Acute-Onset Subtypes in Pediatric Obsessive-Compulsive Disorder.
    Jaspers-Fayer F; Han SHJ; Chan E; McKenney K; Simpson A; Boyle A; Ellwyn R; Stewart SE
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):332-341. PubMed ID: 28121463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special issue on pediatric acute-onset neuropsychiatric syndrome.
    Chang K; Koplewicz HS; Steingard R
    J Child Adolesc Psychopharmacol; 2015 Feb; 25(1):1-2. PubMed ID: 25695940
    [No Abstract]   [Full Text] [Related]  

  • 12. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PANDAS following amygdalectomy].
    Aróstegui S; Agüero JA; Escar C
    An Sist Sanit Navar; 2003; 26(2):287-90. PubMed ID: 12951624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients.
    Frankovich J; Thienemann M; Pearlstein J; Crable A; Brown K; Chang K
    J Child Adolesc Psychopharmacol; 2015 Feb; 25(1):38-47. PubMed ID: 25695943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive disorder in youth: assessment and treatment.
    Wells JG
    J Clin Psychiatry; 2014 May; 75(5):e13. PubMed ID: 24922491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma pneumoniae infection and obsessive-compulsive disease: a case report.
    Ercan TE; Ercan G; Severge B; Arpaozu M; Karasu G
    J Child Neurol; 2008 Mar; 23(3):338-40. PubMed ID: 18079308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric acute-onset neuropsychiatric syndrome.
    Murphy TK; Gerardi DM; Leckman JF
    Psychiatr Clin North Am; 2014 Sep; 37(3):353-74. PubMed ID: 25150567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Pediatric Acute-Onset Neuropsychiatric Disorder in a Large Survey Population.
    Calaprice D; Tona J; Murphy TK
    J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):92-103. PubMed ID: 28832181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.